North America and Europe Artificial Pancreas Systems Market to Gain Significant Value US$ 280 Mn by 2026
The Diabetes Type 1 segment was estimated to account for a little more than 95% market share in terms of value in the North America and Europe artificial pancreas systems market by 2016 end and is expected to experience an increase of more than 200 BPS in its market share by 2026 over 2016.
View full press release